The global Artificial Kidney Market Growth Accelerated by Growing Prevalence of Kidney Diseases
Artificial kidneys are medical devices that mimic the functions of biological kidneys such as filtering waste and excess fluid from the blood and regulating electrolyte and acid-base balance. Growing prevalence of kidney diseases has heightened demand for artificial kidneys. Rising cases of hypertension, diabetes, and chronic kidney disease have boosted the need for kidney transplants and dialysis procedures. However, organ donation shortages have propelled development of artificial organs.
The global Artificial Kidney Market is estimated to be
valued at US$ 3,358.54 million in 2023 and is expected to exhibit a CAGR of 12%
over the forecast period 2024 to 2031, as highlighted in a new report published
by Coherent Market Insights.
Market key trends:
One of the key trends driving growth in the artificial kidney market is
technological advancements. Vendors are focusing on developing innovative
artificial kidney devices with improved functionalities. For instance, companies
are working on implantable bioartificial kidneys that can fully replace damaged
kidneys and eliminate the need for lifelong dialysis. Such kidney devices are
developed using patient's own cells and biological materials to avoid issues of
transplant rejection. Technological innovations are helping optimize dialysis
procedures and develop miniature kidney devices. This is expected to improve
treatment outcomes and quality of life for patients with renal failure.
Segment Analysis
The global artificial kidney market is dominated by the hemodialysis segment. Hemodialysis systems account for over 90% share of the global market as they are widely used for treatment of kidney failure. These systems effectively remove waste and extra fluid from the blood of patients with impaired or failed kidneys.
Key Takeaways
The global artificial kidney market is expected to witness high growth. The market is projected to rise at a CAGR of 12% during the forecast period of 2024-2031. By 2031, the market size is expected to cross $12 billion.
Regional analysis
North America currently dominates the global artificial kidney market. Higher healthcare expenditure, growing prevalence of chronic kidney diseases, and presence of leading players in the region drive the North American market. Asia Pacific is expected to be the fastest growing region during the forecast period due to rising awareness, improving healthcare infrastructure and increasing investment by key players.
Key players
Key players operating in the artificial kidney market are KAWASUMI LABORATORIES, INC., Nanodialysis, Fresenius SE & Co KGaA, Baxter, ASAHI KASEI MEDICAL CO., LTD, Medtronic, DaVita Inc, Merit Medical Systems, Nipro Medical Corporation, Nikkiso Co Ltd, Braun Melsungen AG and AWAK Technologies. Fresenius leads the global market with over 40% share.
Comments
Post a Comment